1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
CSNK2A1 Pilot Grant Program is sponsored by CSNK2A1 Foundation (administered by Orphan Disease Center, University of Pennsylvania). This program supports investigator-initiated research projects aimed at advancing the biological understanding of OCNDS (Oculo-Cerebro-Neural Syndrome) and/or accelerating the discovery or development of therapeutic approaches.
It seeks to generate high-impact preliminary data, support novel approaches, and position investigators for future external funding. Research priorities include disease mechanisms, variant-level biology, and biomarker discovery or validation.
Get alerted about grants like this
Get emailed when new opportunities from “CSNK2A1 Foundation (administered by Orphan Disease Center, University of Pennsylvania)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Individuals holding a faculty-level appointment at an academic institution or a senior position at a non-profit institution or foundation. Open to the international community. Confirm the full requirements in the official notice before applying.
CSNK2A1 Pilot Grant Program is funded by CSNK2A1 Foundation (administered by Orphan Disease Center, University of Pennsylvania). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
Johns Hopkins is committing $60 million a year to a new Research Resilience Fund for faculty hit by federal grant terminations and delays — and it is not alone. As termination-for-convenience authority expands under the 2026 OMB rules, institutional bridge funding is becoming a structural feature of the research economy. Here is what these funds actually cover, why they are not a substitute for federal money, and how researchers should think about diversifying before the call comes.
Read articleNSF 26-503, the CyberAICorps Scholarship for Service (CyberAI SFS), pays $27,000–$37,000 annual stipends plus full tuition for students who commit to government service in AI and cybersecurity, with institutional awards up to $2.5 million. The Scholarship Track closes July 21, 2026. Here's why placement infrastructure — not coursework — decides which universities win.
Read articleNIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read article